Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Maryland for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Maryland only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Maryland (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Helen Reidler (NPI 1639506553)

Field	Value
Entity Type	Individual
Organization	Helen Reidler
Address	1838 Greene Tree Rd Ste 460
City	Baltimore
State	MD
ZIP	21208
Taxonomy	Medical Physician Assistant
NPI Enumerated	October 9, 2013

Payer Source	Total Paid
Medicare	$578.4K
Medicaid	$0

Key Findings

This provider’s billing is effectively single‑payer Medicare: lifetime Medicare revenue is $578.4K and there is no Medicaid billing on file, so payer mix is highly concentrated on Medicare beneficiaries. The NPI was enumerated 2013-10-09 (~13 years ago), indicating more than a decade of billing history under this enrollment.

Revenue for this provider is heavily concentrated in a very small set of drug administration codes: the precomputed top three Medicare codes account for 74.6% of total Medicare revenue, led by J0897 ($225.7K, 39.1%), J9217 ($149.9K, 26.0%), and J9155 ($54.7K, 9.5%). These three codes together drive the majority of the $578.4K Medicare footprint, showing a concentrated dependence on a few high‑value therapies.

The mix of top codes points to an office‑based infusion/procedural practice focused on oncology/urology therapeutics: J0897 (denosumab), J9217 (leuprolide acetate depot), and J9155 (degarelix) are injectable hormonal or bone‑targeted agents, and the provider also bills bladder instillation and BCG-related codes such as J9030 and 51720. Substantial billing for infusion/injection codes alongside procedural bladder codes suggests workflow centered on clinic-administered injectables and in-office urology procedures.

Several codes show extreme national standing that would make this provider a notable source of specific drugs: J9217 ranks #2 of 3683 providers (100th percentile) and is labeled an extreme outlier, and J9155 ranks #7 of 205 providers (97th percentile) and is also an extreme outlier. Those rankings indicate this provider furnishes far above typical national volume for these depot hormonal agents, making them a major national contributor for those specific drugs.

Other high-volume items show mixed competitive signals: J0897 ranks #765 of 10057 providers (92th percentile) and is described as typical/unremarkable volume for that code, while the office E/M code 99213 generated $50.1K (8.7% of Medicare revenue) and ranks #9068 of 457151 providers (98th percentile) with a characterization of notably above typical national volume. This pattern—very high relative volume for some drug codes combined with above‑typical E/M visit volume—suggests the practice pairs frequent procedural/injection encounters with routine outpatient follow-up.

Claim counts and per‑claim payments highlight operational characteristics and reimbursement structure: for example J0897 shows 12.5K claims at an $18 avg paid/claim, J9155 shows 18.2K claims at a $3 avg paid/claim, and J9217 shows 1.1K claims at a $134 avg paid/claim. The combination of very high claim counts with low average paid per claim for some injectables indicates high-frequency administration of low‑unit‑price billables alongside less frequent, higher‑paid depot injections.

There is additional evidence of a procedure-oriented urology/oncology practice beyond infusables: bladder irrigation and instillation codes (51720, 51705, 51798, 51702) and BCG J9030 appear in the top 25, collectively contributing to the clinical service mix. These procedure codes—each contributing smaller shares of revenue—support a model that pairs medicinal infusions with urologic office procedures.

The revenue concentration in a few injectable/drug codes creates business risk and competitive exposure: because 74.6% of Medicare revenue is driven by the top three codes, changes in reimbursement, utilization guidelines, or drug availability for J0897, J9217, or J9155 could disproportionately affect overall revenue. For payer or competitor analysts, this profile flags the provider as specialized in a narrow set of therapies with limited Medicaid diversification to offset Medicare changes.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

25 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0897	Injection, denosumab, 1 mg	12,540	$20	$225.7K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	1,120	$130	$149.9K
J9155	Injection, degarelix, 1 mg	18,240	$1	$54.7K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	860	$60	$50.1K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	440	$90	$38.1K
96402	In this procedure, the provider administers chemotherapy either subcutaneously, meaning under the skin, or intramuscularly, meaning in muscle. He administers a hormonal anti–neoplastic drug.	430	$20	$10K
J9030	BCG live intravesical instillation, 1 mg	3,250	$1	$6.5K
51720	This is a common treatment for bladder cancer. It involves instilling an anticarcinogenic agent into the bladder through a catheter. The provider leaves the agent in the bladder for a period of time…	90	$70	$5.9K
51705	In this procedure, the provider performs a simple removal of a tube that he previously places into a patient’s bladder and replaces it with a new tube through the same incision.	80	$70	$5.1K
51798	Providers perform this ultrasound to measure the volume of residual urine in the bladder.	480	$10	$4.3K

Showing 1–10 of 25

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 25 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Maryland Distribution

Helen Reidler — 6 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Maryland

Full comparison — all codes billed, vs. state median

25 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0897	10	340	3,600	$20	$114.4K
J9217	1	100	150	$130	$27.3K
99214	393	10,270	150	$90	$24.1K
99233	446	2,770	80	$100	$16.6K
99490	72	220	110	$50	$15K
J9155	1	10	5,040	$1	$14.9K
96401	28	190	140	$60	$12.5K
99213	92	9,280	100	$60	$12.5K
99232	459	3,350	80	$60	$11.1K
99223	454	2,930	40	$140	$10.3K

Showing 1–10 of 25

Related Providers

Other providers that share a Tax Identification Number (TIN) with Helen Reidler, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Mohammed Razvi	MD	Vascular & Interventional Radiology Physician	$3.4M	$0
Yudhishtra Markan	MD	Hematology & Oncology Physician	$3M	$0
Benjamin Lowentritt	MD	Urology Physician	$2.1M	$0
Gayatri Nimmagadda	MD	Hematology & Oncology Physician	$1.9M	$0
Tehmina Ali	MD	Anatomic Pathology Physician	$1.7M	$0
Robert Brookland	MD	Radiation Oncology Physician	$1.4M	$0
Enrico Giangeruso	VA	Anatomic Pathology & Clinical Pathology Physician	$1.4M	$0
Michael Isaacson	MD	Urology Physician	$1.3M	$0
Brandywine Urology Consultants PA	DE	Urology Physician	$0	$1.2M
Geoffrey Neuner	MD	Radiation Oncology Physician	$1.1M	$0

Nearby Providers

Other providers in the same ZIP code as Helen Reidler, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Prologue, Inc	MD	Community/Behavioral Health Agency	$0	$18.1M
Health Rite Pharmacy & Medical Supply Inc	MD	Community/Retail Pharmacy	$1.6K	$16.5M
C&c Advocacy And Health Services, Inc.	MD	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$12.6M
The Monumental Group LLC	MD	Substance Use Disorder Rehabilitation Clinic/Center	$0	$9.1M
The Therapy Spot	MD	Occupational Therapy Assistant	$0	$8.5M
Pikesville Health Services LLC	MD	Methadone Clinic	$168.1K	$5.6M
Acme Medical Supplies, Inc.	MD	Oxygen Equipment & Supplies (DME)	$0	$5.3M
Empowerment Therapy Services Of Maryland, LLC	MD	Community/Behavioral Health Agency	$0	$5.1M
Empowerment Therapy Services Of Maryland, LLC	MD	Rehabilitation Clinic/Center	$0	$4.5M
Healthy Life Adult Medical Day Center, LLC	MD	Adult Day Care Clinic/Center	$0	$4.2M

Helen Reidler — Billing Profile & Reimbursement Data

Sign up for Helen Reidler — Billing Profile & Reimbursement Data policy alerts

Helen Reidler — Billing Profile & Reimbursement Data

Sign up for Helen Reidler — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References